A doctor has issued a warning to those using weight loss injections. He cautioned that they can lead to a reduction in bone ...

Biocon is introducing Bosaya (denosumab-kyqq), a biosimilar to Prolia, and Aukelso (denosumab-kyqq), a biosimilar to Xgeva.

(Nasdaq: ENTX) (“Entera” or the “Company”), a leader in the development of oral peptides, today announced it will host a virtual Key Opinion Leader (KOL) webinar focused on the osteoporosis treatment ...

A recent FDA approval means consumers now have to GLP-1 weight loss pills to choose from as an alternative to the traditional ...

A doctor has issued a warning to those using weight loss injections. He cautioned that they can lead to a reduction in bone ...

Biocon makes US commercial launch of Bosaya and Aukelso, denosumab biosimilars: Our Bureau, Bengaluru Wednesday, April 8, 2026, 16:10 Hrs [IST] Biocon has made a commercial launch ...

An expert has shared a potential risk of rapid weight loss ...

I live in hay fever hell – but a new treatment is giving me hope - IN FOCUS : Injections against hay fever were stopped after ...

Q. My poor daughter has been suffering ever since menopause. Her muscles are weak and she feels tired, but she can’t sleep ...

In the early 2020s, interest in GLP-1 weight loss drugs exploded. Now, as we move deeper into the decade, a new buzzword is ...

The AI-powered weight loss app is a product category that has been steadily improving for a number of years, situated ...

ALMOST nine in ten slimmers on weight loss jabs fail to eat enough protein, risking hair loss and saggy skin, research ...